Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Jade Biosciences, Inc. | 3,401,544 | reported | 02 Jul 2021 | tx 3+3,758,686−10,565,238 |
| CinCor Pharma, Inc. | 0 | reported | 11 Jan 2022 | tx 4+5,573,949−17,846,428 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jan 2022 | PURCHASE | CinCor Pharma, Inc. | 325,000 | 16.00 USD | |
| 11 Jan 2022 | CONVERSION | CinCor Pharma, Inc. | 5,248,949 | — | |
| 11 Jan 2022 | CONVERSION | CinCor Pharma, Inc. | 4,275,000 | 0.00 USD | deriv |
| 11 Jan 2022 | CONVERSION | CinCor Pharma, Inc. | 13,571,428 | 0.00 USD | deriv |
| 02 Jul 2021 | CONVERSION | Jade Biosciences, Inc. | 3,401,544 | — | |
| 02 Jul 2021 | PURCHASE | Jade Biosciences, Inc. | 357,142 | 14.00 USD | |
| 02 Jul 2021 | CONVERSION | Jade Biosciences, Inc. | 10,565,238 | — | deriv |